Barbara Morgan examines how the BIOSECURE act will affect supply chains. US pharma supply chains are shifting amid regulation and geopolitics, with BIOSECURE driving less Asia reliance and more ...

As hub transitions accelerate and digital tools reshape how support is delivered, four patient services experts weigh in on what's driving change in 2026, and what manufacturers need to get right to ...

Live from Asembia AXS26, Austin Russian examines how specialty therapy launches are evolving.

AI-driven cold chain visibility is only as reliable as the data behind it, exposing gaps between compliance, monitoring, and true product conditions.

Manasi Salgaonkar examines how accurate class of trade research enables precise pricing, contract eligibility, and compliance.

Cold chain packaging was built for a stable world. As disruption becomes the norm, pharma logistics teams are rethinking what control actually means and when it has to happen.

Shawn Seamans, Chief Commercial Officer, CoverMyMeds | Authors | Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking ...

EVERSANA's Vikram Anand explains how disconnected PV systems and manual safety processes can create commercial delays after ...

Ten PBMs will integrate TrumpRx cash pricing into RTBT displays, allowing prescribers and patients to compare cash-pay versus plan benefit costs at the point of prescribing. Clinician workflow remains ...

In this week's Pharma Pulse, Trump nominates Heidi Overton to lead the FDA, EVERSANA expands its AI-powered commercialization ...

Cardinal Health's Michelle Britt discusses the operating costs, cash flow strain and reimbursement pressures facing ...

AI in PV can compress the interval between signal observation and documented action, preserving benefit–risk integrity and ...